Paper31366609
8-Aminoquinoline Therapy for Latent Malaria.
Baird JK. Clin Microbiol Rev, 2019. Cited by 101 papers, by iCite.
Cite this record
ConductScience Library. 8-Aminoquinoline Therapy for Latent Malaria. Papers, record 31366609. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31366609
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Aminoquinolines | Major topic |
| Malaria | Major topic |
| Antimalarials | |
| Humans |
Source PubMed
Grants2
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| Wellcome Trust | United Kingdom | PubMed | ||
| 106680/Z/14/Z | Wellcome Trust | United Kingdom | PubMed |
Source PubMed
References244
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 2 | 11425182 | The neglected burden of Plasmodium vivax malaria. | Am J Trop Med Hyg | 2001 | https://conductscience.org/library/papers/11425182 | PubMed |
| 4 | 4386875 | Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. | Blood | 1968 | https://conductscience.org/library/papers/4386875 | PubMed |
| 5 | 20133198 | Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. | Trends Parasitol | 2010 | https://conductscience.org/library/papers/20133198 | PubMed |
| 6 | 6976854 | New tissue schizontocidal antimalarial drugs. | Bull World Health Organ | 1981 | https://conductscience.org/library/papers/6976854 | PubMed |
| 7 | 22900786 | Primaquine radical cure of Plasmodium vivax: a critical review of the literature. | Malar J | 2012 | https://conductscience.org/library/papers/22900786 | PubMed |
| 8 | 828446 | The quartan malarial nephrotic syndrome. | Adv Nephrol Necker Hosp | 1976 | https://conductscience.org/library/papers/828446 | PubMed |
| 9 | 4391843 | Effects of drugs and drug metabolites on erythrocytes from normal and glucose-6-phosphate dehydrogenase-deficient individuals. | Ann N Y Acad Sci | 1968 | https://conductscience.org/library/papers/4391843 | PubMed |
| 10 | 22144436 | Review: Improving the therapeutic index of 8-aminoquinolines by the use of drug combinations: review of the literature and proposal for future investigations. | Am J Trop Med Hyg | 2011 | https://conductscience.org/library/papers/22144436 | PubMed |
| 11 | 26610844 | Summary of anti-malarial prophylactic efficacy of tafenoquine from three placebo-controlled studies of residents of malaria-endemic countries. | Malar J | 2015 | https://conductscience.org/library/papers/26610844 | PubMed |
| 12 | 31229233 | Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000-17: a spatial and temporal modelling study. | Lancet | 2019 | https://conductscience.org/library/papers/31229233 | PubMed |
| 13 | 28850568 | Unsupervised primaquine for the treatment of Plasmodium vivax malaria relapses in southern Papua: A hospital-based cohort study. | PLoS Med | 2017 | https://conductscience.org/library/papers/28850568 | PubMed |
| 14 | 30103751 | Metabolism of primaquine in normal human volunteers: investigation of phase I and phase II metabolites from plasma and urine using ultra-high performance liquid chromatography-quadrupole time-of-flight mass spectrometry. | Malar J | 2018 | https://conductscience.org/library/papers/30103751 | PubMed |
| 15 | 30085149 | Enantiospecific pharmacokinetics and drug-drug interactions of primaquine and blood-stage antimalarial drugs. | J Antimicrob Chemother | 2018 | https://conductscience.org/library/papers/30085149 | PubMed |
| 17 | 27672207 | Screening for Glucose-6-Phosphate Dehydrogenase Deficiency Using Three Detection Methods: A Cross-Sectional Survey in Southwestern Uganda. | Am J Trop Med Hyg | 2016 | https://conductscience.org/library/papers/27672207 | PubMed |
| 18 | 24853873 | First evaluation of glucose-6-phosphate dehydrogenase (G6PD) deficiency in vivax malaria endemic regions in the Republic of Korea. | PLoS One | 2014 | https://conductscience.org/library/papers/24853873 | PubMed |
| 19 | 19209263 | Clinical development of new prophylactic antimalarial drugs after the 5th Amendment to the Declaration of Helsinki. | Ther Clin Risk Manag | 2008 | https://conductscience.org/library/papers/19209263 | PubMed |
| 20 | 24901334 | A high resolution case study of a patient with recurrent Plasmodium vivax infections shows that relapses were caused by meiotic siblings. | PLoS Negl Trop Dis | 2014 | https://conductscience.org/library/papers/24901334 | PubMed |
| 22 | 4250858 | Primaquine induced haemolysis in G-6-PD deficient Burmese. | Trans R Soc Trop Med Hyg | 1970 | https://conductscience.org/library/papers/4250858 | PubMed |
| 23 | 27601524 | High Efficacy of Primaquine Treatment for Plasmodium vivax in Western Thailand. | Am J Trop Med Hyg | 2016 | https://conductscience.org/library/papers/27601524 | PubMed |
| 24 | 16020691 | Plasmodium ovale: parasite and disease. | Clin Microbiol Rev | 2005 | https://conductscience.org/library/papers/16020691 | PubMed |
Cited by83
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42922745 | Parasite and host factors associated with malaria parasite liver stage latency. | Res Sq | 2026 | https://conductscience.org/library/papers/42922745 | PubMed |
| 42761215 | Analytical dilemmas in assessing efficacy of radical cure of vivax malaria. | Lancet Reg Health Southeast Asia | 2026 | https://conductscience.org/library/papers/42761215 | PubMed |
| 42653783 | Revisiting Glutathione Transferases of Plasmodium as Potential Targets for Coadjuvant Therapies and the Development of New Antimalarials. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42653783 | PubMed |
| 42188870 | Tafenoquine: A Breakthrough Option for Babesiosis Treatment. | Trop Med Infect Dis | 2026 | https://conductscience.org/library/papers/42188870 | PubMed |
| 41980931 | Potent acridone antimalarial against all three life stages of Plasmodium. | Nat Commun | 2026 | https://conductscience.org/library/papers/41980931 | PubMed |
| 41953713 | G6PD deficiency in Indonesia: a systematic review and update of prevalence and variant maps in the context of malaria elimination. | Lancet Reg Health West Pac | 2026 | https://conductscience.org/library/papers/41953713 | PubMed |
| 41625564 | Plasmodium vivax elimination from India may need therapeutic efficacy studies - Informed shift to artemisinin-based treatment. | IJID Reg | 2026 | https://conductscience.org/library/papers/41625564 | PubMed |
| 41361889 | Haematologic responses to primaquine used for radical cure of Plasmodium vivax in public health facilities in Ethiopia: a prospective observational study. | Malar J | 2025 | https://conductscience.org/library/papers/41361889 | PubMed |
| 41088393 | FocaL mass drug administration for Plasmodium vivax malaria elimination (FLAME): study protocol for an open-label cluster randomized controlled trial in Peru. | Trials | 2025 | https://conductscience.org/library/papers/41088393 | PubMed |
| 41025349 | A drug repurposing approach reveals targetable epigenetic pathways in Plasmodium vivax hypnozoites. | Elife | 2025 | https://conductscience.org/library/papers/41025349 | PubMed |
| 40827872 | How CYP2D6 Polymorphism Modulates the Community-Wide Risk of Plasmodium vivax Infection: A Panel Study in Amazonian Brazil. | J Infect Dis | 2025 | https://conductscience.org/library/papers/40827872 | PubMed |
| 40799291 | Molecular Mechanisms of Drug-Induced Hemolysis in G6PD Deficiency: Mechanistic Insights. | Oxid Med Cell Longev | 2025 | https://conductscience.org/library/papers/40799291 | PubMed |
| 40764298 | Microhaplotype deep sequencing assays to capture Plasmodium vivax infection lineages. | Nat Commun | 2025 | https://conductscience.org/library/papers/40764298 | PubMed |
| 40179277 | Development of Next-Generation Antimalarial Acridones with Radical Cure Potential. | J Med Chem | 2025 | https://conductscience.org/library/papers/40179277 | PubMed |
| 40152241 | Radical Cure of Plasmodium vivax With Primaquine and CYP2D6 Polymorphism in Southeast Asia. | Clin Infect Dis | 2025 | https://conductscience.org/library/papers/40152241 | PubMed |
| 39992119 | Within-host modeling of primaquine-induced hemolysis in hemizygote glucose-6-phosphate dehydrogenase deficient healthy volunteers. | Antimicrob Agents Chemother | 2025 | https://conductscience.org/library/papers/39992119 | PubMed |
| 39639330 | Human liver organoids are susceptible to Plasmodium vivax infection. | Malar J | 2024 | https://conductscience.org/library/papers/39639330 | PubMed |
| 39339162 | Pharmacokinetic Models of Tafenoquine: Insights for Optimal Malaria Treatment Strategies. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/39339162 | PubMed |
| 39332427 | Primaquine for uncomplicated Plasmodium vivax malaria in children younger than 15 years: a systematic review and individual patient data meta-analysis. | Lancet Child Adolesc Health | 2024 | https://conductscience.org/library/papers/39332427 | PubMed |
| 39331646 | Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis. | PLoS Med | 2024 | https://conductscience.org/library/papers/39331646 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31366609
GET https://conductscience.org/api/papers/v1/31366609/references?page=2